유전자 편집 기술 시장 : 세계 산업 규모, 점유율, 동향, 경쟁, 기회, 예측 - 제공 내용별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Gene Editing Technologies Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Offerings, By Technology, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1878853
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 유전자 편집 기술 시장은 2024년에 57억 8,000만 달러로 평가되었으며, 2030년까지 CAGR 10.30%로 성장하여 104억 1,000만 달러에 달할 것으로 예측됩니다.
유전자 편집 기술이란 생물의 DNA에 매우 특이적인 변화를 가하는 방법을 말하며, 표적 유전체 위치에서 유전 물질을 정밀하게 추가, 제거 또는 변형할 수 있습니다. 시장 성장은 주로 지속적인 기술 발전, 다양한 응용 분야에서 유전자 편집의 유용성 확대, 맞춤형 의료에 대한 수요 증가에 의해 주도되고 있습니다. 또한, 전 세계적으로 증가하는 유전성 질환 및 만성질환의 유병률과 관련 연구에 대한 정부의 막대한 연구비 지원이 시장 확대에 크게 기여하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
57억 8,000만 달러
시장 규모 : 2030년
104억 1,000만 달러
CAGR : 2025-2030년
10.3%
가장 빠르게 성장하는 부문
유전자 편집 서비스
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
이러한 안전 우려로 인한 영향은 개발 지연에 반영되어 있습니다.
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 유전자 편집 기술 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제공 내용별(유전자 편집 제품, 유전자 편집 서비스)
기술별(CRISPR 유전자 편집 기술, 비CRISPR 유전자 편집 기술)
용도별(농업, 바이오메디컬)
최종사용자별(학술기관·연구 센터, 생명과학 기업, 계약 연구기관(CRO)/계약 제조 기관(CMO))
지역별
기업별(2024)
시장 맵
제6장 북미의 유전자 편집 기술 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 유전자 편집 기술 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 유전자 편집 기술 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 유전자 편집 기술 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 유전자 편집 기술 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 유전자 편집 기술 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Addgene Inc.
BRAIN Biotech AG
Cellectis S.A.
Creative Biolabs, Inc.
CRISPR Therapeutics AG
BioRad Laboratories, Inc.
DNA Script SAS
GeneCopoeia, Inc.
Merck KGaA
PerkinElmer Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Gene Editing Technologies Market, valued at USD 5.78 Billion in 2024, is projected to experience a CAGR of 10.30% to reach USD 10.41 Billion by 2030. Gene editing technologies encompass methods enabling highly specific changes to an organism's DNA, facilitating the precise addition, removal, or alteration of genetic material at targeted genomic locations. The market's growth is primarily driven by continuous technological advancements, the expanding utility of gene editing across diverse applications, and increasing demand for personalized medicine. Furthermore, the rising global prevalence of genetic and chronic disorders, coupled with substantial government funding for related research, significantly contributes to market expansion.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.78 Billion
Market Size 2030
USD 10.41 Billion
CAGR 2025-2030
10.3%
Fastest Growing Segment
Gene Editing Services
Largest Market
North America
Key Market Drivers
The global gene editing technologies market is profoundly influenced by continuous advancements in the precision and scope of gene editing tools. Innovations consistently emerge, enhancing the safety and accuracy of genetic modifications. For example, according to Massachusetts Institute of Technology, October 10, 2025, "MIT's new precision gene editing tool could transform medicine," a new system makes 60 times fewer mistakes than previous iterations, significantly improving targeting capabilities. These technological refinements directly enable the expanding therapeutic and research applications of gene editing. As tools become more reliable, the range of treatable diseases broadens, and the feasibility of complex genetic interventions increases. This expansion is evident in the burgeoning clinical pipeline.
Key Market Challenges
Persistent concerns regarding off-target effects present a significant impediment to the growth of the Global Gene Editing Technologies Market. These effects, where unintended genetic alterations occur at locations other than the targeted site, introduce substantial safety risks for patients. Such unpredictable outcomes necessitate extensive preclinical and clinical scrutiny, prolonging development timelines and increasing research expenditures. The inherent unpredictability associated with off-target editing directly influences regulatory bodies' cautious approach to product approvals, leading to more stringent testing requirements and extended observational periods for gene-edited therapies.
The impact of these safety concerns is reflected in development setbacks.
Key Market Trends
Accelerated Development of In Vivo Gene Therapies is a significant trend, representing a critical shift towards direct administration of genetic material into the body, thereby bypassing complex *ex vivo* cell manipulation. This approach offers broader therapeutic applicability, simpler administration, and reduced manufacturing complexities, particularly for systemic diseases or difficult-to-access tissues. According to Towards Healthcare, the *in vivo* gene therapy segment constituted approximately 55% of the gene therapy clinical trials market in 2024, indicating its substantial and growing prevalence. This modality is accelerating clinical development pathways.
Key Market Players
Addgene Inc.
BRAIN Biotech AG
Cellectis S.A.
Creative Biolabs, Inc.
CRISPR Therapeutics AG
BioRad Laboratories, Inc.
DNA Script SAS
GeneCopoeia, Inc.
Merck KGaA
PerkinElmer Inc.
Report Scope:
In this report, the Global Gene Editing Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Gene Editing Technologies Market, By Offerings:
Gene Editing Products
Gene Editing Services
Gene Editing Technologies Market, By Technology:
CRISPR Gene Editing Technology
Non-CRISPR Gene Editing Technology
Gene Editing Technologies Market, By Application:
Agricultural
Biomedical
Gene Editing Technologies Market, By End User:
Academic Institutes and Research Centers
Life Sciences Companies
Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs)
Gene Editing Technologies Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Gene Editing Technologies Market.
Available Customizations:
Global Gene Editing Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Gene Editing Technologies Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Offerings (Gene Editing Products, Gene Editing Services)
5.2.4. By End User (Academic Institutes and Research Centers, Life Sciences Companies, Contract Research Organizations (CROs)/ Contract Manufacturing Organizations (CMOs))
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Gene Editing Technologies Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Offerings
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Gene Editing Technologies Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Offerings
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Canada Gene Editing Technologies Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Offerings
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Mexico Gene Editing Technologies Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Offerings
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Gene Editing Technologies Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Offerings
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gene Editing Technologies Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Offerings
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. France Gene Editing Technologies Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Offerings
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Gene Editing Technologies Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Offerings
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Gene Editing Technologies Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Offerings
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Gene Editing Technologies Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Offerings
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia Pacific Gene Editing Technologies Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Offerings
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Gene Editing Technologies Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Offerings
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Gene Editing Technologies Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Offerings
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. Japan Gene Editing Technologies Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Offerings
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. South Korea Gene Editing Technologies Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Offerings
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Gene Editing Technologies Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Offerings
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Middle East & Africa Gene Editing Technologies Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Offerings
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Gene Editing Technologies Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Offerings
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. UAE Gene Editing Technologies Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Offerings
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. South Africa Gene Editing Technologies Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Offerings
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. South America Gene Editing Technologies Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Offerings
10.2.2. By Technology
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gene Editing Technologies Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Offerings
10.3.1.2.2. By Technology
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Colombia Gene Editing Technologies Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Offerings
10.3.2.2.2. By Technology
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Argentina Gene Editing Technologies Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Offerings
10.3.3.2.2. By Technology
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Gene Editing Technologies Market: SWOT Analysis
